Houston Methodist MD
@houstonmethodistmd.bsky.social
Dr. Jon Toledo, an assistant professor of neurology, discusses why multi-target therapies are more effective than single-target drugs for neurodegenerative diseases.
Why Multi-target Therapies Are More Effective than Single-target Drugs for Neurodegenerative Diseases
Houston Methodist researcher discusses why multi-target therapies are more effective than single-target drugs for neurodegenerative diseases.
spr.ly
June 15, 2026 at 2:00 PM
Dr. Jon Toledo, an assistant professor of neurology, discusses why multi-target therapies are more effective than single-target drugs for neurodegenerative diseases.
Rather than treating continuous monitoring as an add-on, we set out to build a clinical and technical environment where technologies could operate at full scale and deliver measurable clinical impact.
How Houston Methodist uses biotechnology to redefine continuous patient monitoring
Houston Methodist Cypress is leading the hospital system in using innovative, wearable technology to monitor patient care.
spr.ly
June 11, 2026 at 2:00 PM
Rather than treating continuous monitoring as an add-on, we set out to build a clinical and technical environment where technologies could operate at full scale and deliver measurable clinical impact.
In a newly published commentary, our scientist Dr. Keith Syson Chan and collaborators across a national consortium reframe cellular senescence as a powerful — and potentially actionable — signal of cancer risk.
Cellular Senescence Recast as an Early Warning System for Cancer
For decades, cancer research has largely focused on treating advanced disease. But a new commentary from Houston Methodist researcher may help shift that paradigm upstream.
spr.ly
June 8, 2026 at 2:00 PM
In a newly published commentary, our scientist Dr. Keith Syson Chan and collaborators across a national consortium reframe cellular senescence as a powerful — and potentially actionable — signal of cancer risk.
A new Rome V-aligned review, co-authored by Dr. Eamonn Quigley, is changing how gastroenterologists manage conditions like IBS and functional dyspepsia by reframing these disorders through a more integrated lens: the intestinal microenvironment.
Intestinal Microenvironment Offers New Framework for Understanding Disorders of Gut–Brain Interaction
Gastroenterologists have long managed conditions like irritable bowel syndrome and functional dyspepsia without a clear biological roadmap; a new paper recommends looking at them through a new lens.
spr.ly
June 4, 2026 at 2:00 PM
A new Rome V-aligned review, co-authored by Dr. Eamonn Quigley, is changing how gastroenterologists manage conditions like IBS and functional dyspepsia by reframing these disorders through a more integrated lens: the intestinal microenvironment.
Despite its popularity, the term "gut health" lacks precision. A consensus statement from @isappscience.bsky.social, co-chaired by Dr. Eamonn Quigley, aims to give gastroenterologists an actionable definition and framework for evaluating gut function in practice.
Defining Gut Health: ISAPP Consensus Statement Gives Clinicians a Practical Framework
Expert consensus statement gives gastroenterologists a common framework for evaluating the clinical definition of "gut health."
spr.ly
June 1, 2026 at 2:00 PM
Despite its popularity, the term "gut health" lacks precision. A consensus statement from @isappscience.bsky.social, co-chaired by Dr. Eamonn Quigley, aims to give gastroenterologists an actionable definition and framework for evaluating gut function in practice.
Our surgeon-led reporting initiative has demonstrated that transparent data, when introduced with intention, can strengthen culture, improve outcomes and unify a department around shared standards of excellence.
Surgeon-Led Performance Reporting Improves Outcomes
At Houston Methodist, surgeon-led, risk-adjusted reporting fostered trust, culture change and measurable gains in mortality and length of stay.
spr.ly
May 28, 2026 at 2:00 PM
Our surgeon-led reporting initiative has demonstrated that transparent data, when introduced with intention, can strengthen culture, improve outcomes and unify a department around shared standards of excellence.
Researchers, led by Dr. Eamonn Quigley, evaluated next-gen capsule technology for GI motility disorders, highlighting the potential for scalable, noninvasive diagnostics. spr.ly/63329BBskbW
Non-Invasive, Next-Generation Gastrointestinal Motility Systems
Houston Methodist researchers participated in a prospective study comparing two wireless motility devices and validated the Atmo Capsule from Atmo Biosciences as an effective method for assessing gastrointestinal transit.
spr.ly
May 25, 2026 at 2:00 PM
Researchers, led by Dr. Eamonn Quigley, evaluated next-gen capsule technology for GI motility disorders, highlighting the potential for scalable, noninvasive diagnostics. spr.ly/63329BBskbW
New research, co-authored by our neuro-ophthalmologist Dr. Andrew Lee, offers one of the most comprehensive looks yet at how spaceflight conditions affect the front of the eye — and what those changes could mean for both astronaut safety and terrestrial medicine.
New Insight into Ocular Surface Risk Reshapes How We Think About Eye Health Beyond Earth
New research from Houston Methodist offers a clear glance at how spaceflight affects the surface of the eye.
spr.ly
May 18, 2026 at 2:00 PM
New research, co-authored by our neuro-ophthalmologist Dr. Andrew Lee, offers one of the most comprehensive looks yet at how spaceflight conditions affect the front of the eye — and what those changes could mean for both astronaut safety and terrestrial medicine.
A clinical trial, led by Dr. Mas Takashima, is providing strong long-term evidence that a minimally invasive, office-based procedure can deliver sustained relief for patients with chronic rhinitis.
Chronic Rhinitis Treatment Shows Durable Results at Three-Year Mark
A Houston Methodist–led clinical trial shows long-lasting relief for chronic rhinitis following temperature-controlled radiofrequency ablation.
spr.ly
May 8, 2026 at 2:00 PM
A clinical trial, led by Dr. Mas Takashima, is providing strong long-term evidence that a minimally invasive, office-based procedure can deliver sustained relief for patients with chronic rhinitis.
We sat down with our assistant professor of neurology Dr. Jon Toledo to shed light on why Lewy pathology must be a crucial consideration when designing clinical trials for neurodegenerative diseases.
Why Lewy pathology must be a critical consideration in the Design of Clinical Trials for Neurodegenerative Diseases: Dr. Jon B. Toledo explains
Houston Methodist researcher discusses why Lewy pathology must be a critical consideration in the design of clinical trials for neurodegenerative diseases.
spr.ly
May 6, 2026 at 2:00 PM
We sat down with our assistant professor of neurology Dr. Jon Toledo to shed light on why Lewy pathology must be a crucial consideration when designing clinical trials for neurodegenerative diseases.
A multicenter randomized controlled trial, co-authored by Drs. Omar Ahmed and Mas Takashima, has demonstrated that impedance-controlled multipoint radiofrequency ablation significantly improves symptoms and quality of life for patients with chronic rhinitis.
Houston Methodist-Led Trial Validates Next-Generation Radiofrequency Ablation for Chronic Rhinitis
New study demonstrates that impedance-controlled multipoint radiofrequency ablation significantly improves symptoms and quality of life for patients with chronic rhinitis.
spr.ly
May 4, 2026 at 2:00 PM
A multicenter randomized controlled trial, co-authored by Drs. Omar Ahmed and Mas Takashima, has demonstrated that impedance-controlled multipoint radiofrequency ablation significantly improves symptoms and quality of life for patients with chronic rhinitis.
Join us for the 10th Annual #Cardiology for the Non-Cardiologist Conference. This event will teach non-cardiovascular health care providers to identify common risk factors and understand guidelines for #cardiovascular diseases.
Register: spr.ly/63325B6orvl
Register: spr.ly/63325B6orvl
May 1, 2026 at 2:00 PM
Join us for the 10th Annual #Cardiology for the Non-Cardiologist Conference. This event will teach non-cardiovascular health care providers to identify common risk factors and understand guidelines for #cardiovascular diseases.
Register: spr.ly/63325B6orvl
Register: spr.ly/63325B6orvl
Flu season has become more than a clinical challenge — it’s a real-world stress test for the health system’s artificial intelligence ecosystem. See how our organization’s digital infrastructure supports clinicians under pressure.
Flu Season as an Enterprise-scale AI Stress Test at Houston Methodist
Seasonal surges reveal where information flow breaks down, where cognitive load spikes and where technology can meaningfully reshape care delivery.
spr.ly
April 29, 2026 at 2:00 PM
Flu season has become more than a clinical challenge — it’s a real-world stress test for the health system’s artificial intelligence ecosystem. See how our organization’s digital infrastructure supports clinicians under pressure.
We spoke with Dr. Omar Ahmed about his work to better understand the unresolved questions in chronic rhinosinusitis research and treatment, and how these insights could ultimately inform clinical care.
Genetic Heterogeneity in Chronic Rhinosinusitis
Dr. Omar G. Ahmed and his team have researched chronic rhinosinusitis (CRS) and discovered that race and genetics play a role in how CRS affects patients across races.
spr.ly
April 27, 2026 at 2:00 PM
We spoke with Dr. Omar Ahmed about his work to better understand the unresolved questions in chronic rhinosinusitis research and treatment, and how these insights could ultimately inform clinical care.
Most patients with hepatocellular carcinoma fail to respond to current immune checkpoint inhibitors. New research, led by Dr. Dan Duda, suggests tumor-associated B cells may be a key driver of resistance and a promising therapeutic target.
Researchers Identify B Cells as Driver of Immunotherapy Resistance in Liver Cancer
New research from a Houston Methodist investigator suggests that tumor-associated B cells may help hepatocellular carcinoma cells evade immune detection, leading to poor outcomes with immune checkpoint inhibition.
spr.ly
April 24, 2026 at 2:00 PM
Most patients with hepatocellular carcinoma fail to respond to current immune checkpoint inhibitors. New research, led by Dr. Dan Duda, suggests tumor-associated B cells may be a key driver of resistance and a promising therapeutic target.
A new 3D-printed vacuum coupler, designed by Dr. Carly S. Filgueira, reduced cardiac motion during ultrasound-mediated imaging in an open-chest heart model, according to our study that shows promise for reducing inaccuracies and improving patient outcomes.
Houston Methodist researchers push the envelope with an innovative vacuum coupler for open-chest cardiac ultrasound mediated imaging.
Houston Methodist researchers push the envelope with an innovative vacuum coupler that enhances image integrity and offers superior data for open-chest cardiac ultrasound-mediated imaging.
spr.ly
April 22, 2026 at 2:00 PM
A new 3D-printed vacuum coupler, designed by Dr. Carly S. Filgueira, reduced cardiac motion during ultrasound-mediated imaging in an open-chest heart model, according to our study that shows promise for reducing inaccuracies and improving patient outcomes.
We’ve announced a collaboration with Texas Children's to establish the Fondren IBD Transition Program, an initiative designed to support children & young adults living with inflammatory bowel disease as they make the transition from pediatric to adult care.
Houston Methodist
Houston Methodist and Texas Children’s have announced a transformational collaboration to establish the Fondren IBD Transition Program, an initiative designed to support children and young adults living with inflammatory bowel disease (IBD) as they make the transition from pediatric to adult...
spr.ly
April 20, 2026 at 2:00 PM
We’ve announced a collaboration with Texas Children's to establish the Fondren IBD Transition Program, an initiative designed to support children & young adults living with inflammatory bowel disease as they make the transition from pediatric to adult care.
Join us for the 10th Annual #Cardiology for the Non-Cardiologist Conference. This event will teach non-cardiovascular health care providers to identify common risk factors and understand guidelines for #cardiovascular diseases.
Register: spr.ly/63325B6orSc
Register: spr.ly/63325B6orSc
April 17, 2026 at 2:00 PM
Join us for the 10th Annual #Cardiology for the Non-Cardiologist Conference. This event will teach non-cardiovascular health care providers to identify common risk factors and understand guidelines for #cardiovascular diseases.
Register: spr.ly/63325B6orSc
Register: spr.ly/63325B6orSc
ICU survival is just the beginning. Our Critical Care Recovery Clinic integrates intensivists, therapists, pharmacists & psychologists to close gaps in post-ICU care and improve long-term outcomes. Advancing survivorship care step by step.
Houston Methodist Critical Care Recovery Clinic Marks Two Years of Redefining ICU Survivorship
Innovative clinic offers comprehensive support for patients and family members experiencing post intensive care syndrome.
spr.ly
April 6, 2026 at 2:00 PM
ICU survival is just the beginning. Our Critical Care Recovery Clinic integrates intensivists, therapists, pharmacists & psychologists to close gaps in post-ICU care and improve long-term outcomes. Advancing survivorship care step by step.
Our critical care specialist Dr. Hina Faisal has received a NIH career development award to investigate whether immersive virtual reality therapy can help prevent ICU delirium.
Can Virtual Reality Prevent ICU Delirium? NIH Award Supports Houston Methodist Study
Houston Methodist critical care specialist Dr. Hina Faisal has received a National Institutes of Health career development award to investigate whether immersive virtual reality therapy can help prevent ICU delirium.
spr.ly
April 2, 2026 at 2:00 PM
Our critical care specialist Dr. Hina Faisal has received a NIH career development award to investigate whether immersive virtual reality therapy can help prevent ICU delirium.
Alzheimer’s and Lewy pathology frequently co-occur and significantly impact clinical presentation & cognitive decline. Understanding these overlaps is essential for accurate diagnosis, biomarkers & combination therapies.
Houston Methodist Neurologist Explains the Importance of Studying Co-Pathologies in Neurodegenerative Diseases
Houston Methodist researcher discusses why co-pathologies are critically important to study in neurodegenerative diseases.
spr.ly
March 30, 2026 at 2:00 PM
Alzheimer’s and Lewy pathology frequently co-occur and significantly impact clinical presentation & cognitive decline. Understanding these overlaps is essential for accurate diagnosis, biomarkers & combination therapies.
A new algorithm provides a more accurate method for estimating left ventricular filling pressure (LVFP) by echocardiography, according to a validation study led by Medical Director of our Echocardiography Laboratory Dr. Sherif Nagueh.
Houston Methodist-Led Study Validates Improved Echocardiographic Algorithm for Estimating LV Filling Pressure
Study validates a more accurate method for estimating left ventricular filling pressure (LVFP) by echocardiography.
spr.ly
March 25, 2026 at 2:00 PM
A new algorithm provides a more accurate method for estimating left ventricular filling pressure (LVFP) by echocardiography, according to a validation study led by Medical Director of our Echocardiography Laboratory Dr. Sherif Nagueh.
The coexistence of Lewy body dementia and Alzheimer’s leads to significantly faster rates of cognitive decline compared to either pathology alone, according to our study that begins unraveling the interplay between the two diseases.
Co-pathologies in Neurodegenerative Diseases
Studies conducted at Houston Methodist on Alzheimer’s disease pathology and Lewy pathology may improve the design of clinical trials for neurodegenerative diseases and patient outcomes.
spr.ly
March 23, 2026 at 2:00 PM
The coexistence of Lewy body dementia and Alzheimer’s leads to significantly faster rates of cognitive decline compared to either pathology alone, according to our study that begins unraveling the interplay between the two diseases.
Patients on long-term steroids face nearly three times the risk of developing life-threatening blood clots after complex spine surgery, according to a study led by our orthopedic spine surgeon Dr. Comron Saifi.
Study Finds Chronic Steroid Use Greatly Increases Risk of Deadly Blood Clots After Complex Spine Surgery
A Houston Methodist study found that patients on long-term steroids have a 3X higher risk of blood clots after spinal surgery than non steroid users.
spr.ly
March 20, 2026 at 2:00 PM
Patients on long-term steroids face nearly three times the risk of developing life-threatening blood clots after complex spine surgery, according to a study led by our orthopedic spine surgeon Dr. Comron Saifi.
Our thoracic surgery division, under Dr. Min Kim's leadership, has set new benchmarks for outcomes and innovation thanks to a data-driven culture, robotic adoption & enhanced recovery pathways.
Inside the Evolution of a Thoracic Surgery Program
Dr. Min Kim came to Houston Methodist with a plan: half his time would be spent modeling lung cancer and metastasis, and the other half caring for patients. But four years into practice, that plan changed abruptly. After his senior partner left for Mayo Clinic, leadership approached him with a question that would reshape his career: Do you want to do the job of division chief with the title, or without it? Dr. Kim took the title and set out to build a program that focused on two emerging pillars: robotic surgery and enhanced recovery after surgery (ERAS). A decade ago, neither was widely adopted in thoracic care. Today, they define the division’s identity.
www.houstonmethodist.org
March 18, 2026 at 2:00 PM
Our thoracic surgery division, under Dr. Min Kim's leadership, has set new benchmarks for outcomes and innovation thanks to a data-driven culture, robotic adoption & enhanced recovery pathways.